ABSTRACT
BACKGROUND AND OBJECTIVES Chronic kidney disease (CKD) is a significant public health concern. Patients affected by chronic kidney problems often experience symptoms, such as pain and mood disorders, while awaiting a transplant. Nonpharmacological interventions with no collateral effects are necessary for managing the symptoms. The objective of this study was to assess the effects of transcranial direct current stimulation (tDCS) on pain, anxiety, and depression in patients affected by CKD.
METHODS This is a single-center, double-blinded, parallel, randomized sham-controlled clinical trial. The interventions consisted of ten non-consecutive sessions of anodal tDCS over the left dorsolateral prefrontal cortex and the cathode over the contralateral supraorbital region. Each session lasted 20 min with an intensity of 2 mA. This clinical trial included patients with CKD who experienced chronic pain and had been undergoing hemodialysis for more than three months. There were four assessments: at baseline, after the first and last intervention, and seven days after the last intervention (follow-up).
RESULTS There was a significant interaction between group and time regarding pain (p=0.0005; partial η2 = 0.362) and a significant time interaction (p = 0.0005, partial η2 = 0.659) with significant differences between groups at day 10 (p= 0.004; partial η2 = 0.37) and follow-up (p= 0.03; partial η2 = 0.22). Additionally, there was a significant difference between groups for anxiety (p<0.02, partial η2= 0.258).
CONCLUSION After ten sessions of tDCS, patients affected by chronic kidney disease showed a reduction in pain, anxiety, and depression.
Keywords:
Chronic pain; Hemodialysis; Neuromodulation; Noninvasive brain stimulation; Quality of life
HIGHLIGHTS
Patients affected by chronic kidney disease often suffer from pain and mood disorders
The study involved ten non-consecutive sessions of anodal transcranial direct current stimulation (tDCS) over the left dorsolateral prefrontal cortex, with each session lasting 20 minutes at 2 mA
tDCS provided significant reductions in pain and anxiety, with notable differences between groups at day 10 and follow-up assessments
Thumbnail
Thumbnail
Thumbnail


